in this issue
Regions :: Western Europe :: Germany
BASF and Bend Research collaborate to improve solubility and bioavailability of drugs
11:12 AM MST | February 21, 2013 | Deepti Ramesh
BASF says that it has signed an agreement with Bend Research (Bend, OR) to jointly evaluate and develop novel excipients to enhance the solubility and bioavailability of poorly soluble drugs. Bioavailability is the measure of the amount of drug that is actually absorbed from a given dose. Bend Research is a company that provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical trial quantities of drug candidates in its facilities, and advances promising drug candidates from conception through...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee